Monograph
M01AC02 - Tenoxicam |
Propably not porphyrinogenic |
PNP |
Rationale
Substrate of CYP 2C9. Two references consider it (probably) safe for use.
Chemical description
Tablet; 20 mg/d. Analgesic with antipyretic och anti-inflammatory effects for short-time treatment of light to moderate pain Oxicam derivative extensively metabolized (CYP 2C9), mainly to the 5-hydroxyderivative. Inhibitor of CYP 2C9. South African list: use with care. French list: authorized
Similar drugs
Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia).
Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway).
What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names
are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Belgium
United Kingdom
Denmark
Luxembourg© NAPOS 2024